Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Hepion Pharmaceuticals, Inc. (HEPA) had Free Cash Flow per Share of $-2.54 for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
-- |
|
$-4.87M |
|
-- |
|
-- |
|
$4.46M |
|
$-4.46M |
|
$-0.41M |
|
$-4.87M |
|
$-4.87M |
|
$-4.87M |
|
$-4.87M |
|
$-4.87M |
|
$-4.87M |
|
$-4.46M |
|
$-3.98M |
|
6.72M |
|
6.72M |
|
$-0.72 |
|
$-0.72 |
|
| Balance Sheet Financials | |
$3.53M |
|
-- |
|
$0.18M |
|
$3.72M |
|
$2.72M |
|
-- |
|
$1.41M |
|
$4.12M |
|
$-2.10M |
|
$-0.41M |
|
$-0.41M |
|
6.96M |
|
| Cash Flow Statement Financials | |
$-17.06M |
|
$-0.60M |
|
$4.35M |
|
$14.79M |
|
$1.50M |
|
$-13.29M |
|
$0.76M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.30 |
|
-- |
|
-- |
|
-- |
|
-5.18 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-17.06M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
231.51% |
|
1196.49% |
|
-130.98% |
|
1196.49% |
|
$-0.06 |
|
|
Free Cash Flow per Share |
$-2.54 |
$-2.54 |
|